China

Latest

Line chart titled "China's Health Aid, 2000–23" showing inflation-adjusted Chinese health commitments to low- and middle-income countries in 2023 U.S. dollars. Aid remained mostly below $400 million from 2000 to 2004, then spiked to approximately $1.3 billion in 2005 following a large loan for Cuban hospitals, before falling back to under $400 million through 2014. After China introduced the Health Silk Road in 2015, aid rose to roughly $700 million in 2016, then fluctuated between $400–500 million through 2020. Aid surged dramatically during the COVID-19 pandemic, peaking near $2.4 billion around 2021–2022, then dropped sharply to near zero in 2023. Source: AidData
Trade

China's Health Silk Road and Soft Power

Understanding China's previous engagement on health development can inform its future strategy as the United States pulls back

Women work in a laboratory of Chinese vaccine maker Sinovac Biotech, developing an experimental COVID-19 vaccine, during a government-organized media tour, in Beijing, China, on September 24, 2020.
Governance

China's Evolving Global Health Leadership 

China's global health ascendence offers alternatives for partnerships that differ from traditional, U.S.-dominated models